OOIR: Observatory of International Research

Papers

(The median citation count of Annual Review of Medicine is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The Gut–Brain Axis	268
Phage Therapy for Antibiotic-Resistant Bacterial Infections	244
mRNA Vaccines in the COVID-19 Pandemic and Beyond	146
Hepcidin and Iron in Health and Disease	118
The Role of Exercise in Management of Mental Health Disorders: An Integrative Review	112
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment	111
The Gut Microbiome and Inflammatory Bowel Diseases	108
Hepatocellular Carcinoma Immunotherapy	104
Engineering IL-2 to Give New Life to T Cell Immunotherapy	80
Cardiovascular Effects of Particulate Air Pollution	79
New Therapeutics for Ulcerative Colitis	73
Diagnosis and Treatment of Helicobacter pylori Infection	72
Post-COVID-19 Condition	71
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines	69
Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches	68
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies	65
COVID-19 and Diabetes	65
Direct-to-Consumer Genetic Testing: Value and Risk	56
Clinical Perspectives on IgG4-Related Disease and Its Classification	55
COVID-19: Challenges of Viral Variants	55
Hematopoietic Stem Cell Transplantation for Autoimmune Disease	55
Advances in Chronic Obstructive Pulmonary Disease	54
COVID-19: Inflammatory Profile	52
Synchronizing Brain Rhythms to Improve Cognition	50
Cytokine Storm Syndrome	49

New Therapeutics for Hepatitis B: The Road to Cure	48
COVID-19 Vaccines: Adenoviral Vectors	44
Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression	44
Contemporary Management of Thyroid Nodules	44
Wearable Devices to Monitor and Reduce the Risk of Cardiovascular Disease: Evidence and Opportunities	43
Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches	43
Therapeutics Targeting Mutant KRAS	43
Adeno-Associated Virus Gene Therapy for Hemophilia	42
Aspirin in the Prevention of Colorectal Neoplasia	42
Hypoxia Reduction Sensitizes Refractory Cancers to Immunotherapy	40
Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone	40
Biological Phenotyping in Sepsis and Acute Respiratory Distress Syndrome	38
Toward Better Understanding and Management of CAR-T Cell–Associated Toxicity	37
New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics	36
Organoid Models for Infectious Disease	34
Enteroviruses and Type 1 Diabetes: Multiple Mechanisms and Factors?	33
Regulation of Erythropoiesis by the Hypoxia-Inducible Factor Pathway: Effects of Genetic and Pharmacological Perturbations	32
The Gut Microbiome: Connecting Diet, Glucose Homeostasis, and Disease	31
Cystic Fibrosis Modulator Therapies	28
Novel Targets for Alzheimer's Disease: A View Beyond Amyloid	27
Gene-Targeting Therapeutics for Neurological Disease: Lessons Learned from Spinal Muscular Atrophy	26
Clonal Hematopoiesis and Its Impact on Human Health	26
Lymphatic Vasculature: An Emerging Therapeutic Target and Drug Delivery Route	25
Fatty Liver Disease: Diagnosis and Stratification	24
Hypertrophic Cardiomyopathy: New Concepts and Therapies	24
Neurologic Manifestations and Complications of COVID-19	24
Autoimmune Endocrinopathies: An Emerging Complication of Immune Checkpoint Inhibitors	23
Clinical Phenotypes of Cystic Fibrosis Carriers	23
COVID-19 Critical Illness: A Data-Driven Review	22
Clinically Suspected and Biopsy-Proven Myocarditis Temporally Associated with SARS-CoV-2 Infection	21
SGLT2 Inhibitors: The Sweet Success for Kidneys	20
Framework and Strategies to Eliminate Disparities in Colorectal Cancer Screening Outcomes	20
Maternal Mortality in the United States: Trends and Opportunities for Prevention	20
New Approaches to Glioblastoma	19
Aspirin in the Prevention of Cardiovascular Disease and Cancer	19
Spontaneous Coronary Artery Dissection: New Insights into This Not-So-Rare Condition	18
Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children	17
All the Tau We Cannot See	17
Advances in Human Lung Transplantation	17
Treating Coronary Artery Disease: Beyond Statins, Ezetimibe, and PCSK9 Inhibition	17
Gender-Affirming Care of Transgender and Gender-Diverse Youth: Current Concepts	17
Diverse Approaches to Gene Therapy of Sickle Cell Disease	16
FGFR2 Inhibition in Cholangiocarcinoma	16
Club Cell Secretory Protein in Lung Disease: Emerging Concepts and Potential Therapeutics	16
Advances and Applications of Polygenic Scores for Coronary Artery Disease	15
COVID-19 and Kidney Disease	15
A Tale of Two Checkpoints: ATR Inhibition and PD-(L)1 Blockade	15